Increased use of ACE inhibitors and ARBs is linked to rising admissions for acute kidney injury (AKI) say UK researchers.
The team from Cambridge University estimated that the rise in prescriptions for ACE inhibitors and ARBs may have accounted for around 15% of the rise in AKI hospitalisations over the period 2007/08 to 2010/11 – or one in seven of the extra AKI admissions recorded over this time.